바이오모아 (BioMoa) — ADC · Antibody

9268프로그램 35FDA 승인

0오늘 방문

572누적 방문

8122갱신 대기 S–CData Tier S/A/B차세대 1068HER2 breast 5456Antibody 2744CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

ADCBiologicstalePresage BiosciencesPhase 1

AZD9592 (AZD9592)

Head and Neck Squamous Cell Carcinoma · Advanced Solid Tumours

#AdvancedSolidTumours#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 2상태 ACTIVE

CGTBiologicChongqing Precision Biotech Co.…Phase 1

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

AML (Acute Myeloid Leukemia); BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm) · AML (Acute Myeloid Leukemia)

#AMLAcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 2상태 RECRUITING

CGTBiologicstale920th Hospital of Joint Logisti…Phase 2

Anti-CD19 UCAR-NK cells (Anti-CD19 UCAR-NK cells)

B-Cell Lymphoblastic Leukemia/Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 2상태 DISCONTINUED

AntibodyDwight OwenPhase 1

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

Metastatic Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma

#MetastaticLungNon-SmallCellCarci#Antibody#Phase1#항체#면역항체+3

임상시험 2상태 RECRUITING

ADCBiologicstaleSeagen Inc.Phase 1

SEA-TGT (SEA-TGT)

Non-small Cell Lung Cancer; Gastric Carcinoma · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 33.3%임상시험 2상태 DISCONTINUED

CGTBiologicMedical College of WisconsinPhase 2

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

Non Hodgkin Lymphoma (NHL); Mantle Cell Lymphoma (MCL) · Non Hodgkin Lymphoma (NHL)

#NonHodgkinLymphomaNHL#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 2상태 RECRUITING

CGTBiologicstaleBaylor College of MedicinePhase 1

CD30.CAR-EBVST cells (CD30.CAR-EBVST cells)

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type; Classical Hodgkin Lymphoma · CD30

#CD30#CGT#Phase1#세포유전치료#CAR-T+5

임상시험 2상태 DISCONTINUED

CGTBiologicstaleChristian HinrichsPhase 1

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

Gastric Cancer; Breast Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 2상태 RECRUITING

CGTBiologicstaleOriCell Therapeutics Co., Ltd.Phase 2

OriCAR-017 (OriCAR-017)

Relapsed and/or Refractory Multiple Myeloma · Neoplasms, Plasma Cell

#NeoplasmsPlasmaCell#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 2상태 RECRUITING

ADCBiologicstaleNew York Medical CollegePhase 2

AD CP (AD CP)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 1%임상시험 2상태 RECRUITING

CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 2

IM19 CAR-T cells (IM19 CAR-T cells)

NHL · Leukemia

#Leukemia#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 2상태 ACTIVE

AntibodystaleAbbViePhase 3

D2E7 (adalimumab, adalimumab (D2E7))

Ankylosing Spondylitis · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Phase3#항체#면역항체+2

임상시험 2상태 ACTIVE

CGTBiologicstaleUniversity College, LondonPhase 1

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

CD19+ Malignancies: Relapse Post-allogeneic Transplant · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

효능 ORR 77.3%임상시험 2상태 ACTIVE

CGTBiologicstaleCartesian TherapeuticsPhase 2

Descartes-08 (Descartes-08)

Multiple Myeloma · Antisynthetase Syndrome

#AntisynthetaseSyndrome#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 2상태 RECRUITING

CGTBiologicstaleThe Beijing Pregene Science and…Phase 2

CART-19 cells (CART-19 cells)

B-cell Acute Lymphoblastic Leukemia · B-cell Acute Lymphoblastic Leukemia

#B-cellAcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+2

효능 ORR 43.8%임상시험 2상태 ACTIVE

CGTBiologicstaleRobbie MajznerPhase 1

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

Central Nervous System Neoplasms; Brain Tumor · B7-H3

#B7-H3#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 2상태 RECRUITING

ADCBiologicstaleRemeGen Co., Ltd.Phase 1

RC98 (RC98)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 2상태 ACTIVE

ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 2

FDA022-BB05 (FDA022-BB05)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 2상태 ACTIVE

AntibodystaleJanssenApproved

infliximab, azathioprine (infliximab, azathioprine)

Crohn's Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3

임상시험 2상태 ACTIVE

CGTAAVBiologicstaleAdrenas Therapeutics IncPhase 2

AAV BBP-631 (AAV BBP-631)

Congenital Adrenal Hyperplasia · Congenital Adrenal Hyperplasia

#CongenitalAdrenalHyperplasia#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 2상태 RECRUITING

AntibodystaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Hepatocellular Carcinoma (HCC); Immunotherapy · Hepatecellular Carcinoma

#HepatecellularCarcinoma#Antibody#Phase2#항체#면역항체+4

임상시험 2상태 RECRUITING

AntibodystaleRocheApproved

Bevacizumab Injection [Avastin] (Bevacizumab Injection [Avastin])

Retinal Neovascularization; Macular Edema · Retinal Neovascularization

#RetinalNeovascularization#Antibody#Approved#항체#면역항체+3

임상시험 2상태 ACTIVE

ADCBiologicstaleSeagenPhase 2

brentuximab vedotin (Adcetris, Induction without Brentuximab Vedotin)

Hodgkin Lymphoma, Adult · Hodgkin Lymphoma, Adult

#HodgkinLymphomaAdult#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 2상태 RECRUITING

AntibodystaleEli LillyPhase 3

Cetuximab, Capecitabine (Cetuximab, Capecitabine)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2

임상시험 2상태 ACTIVE

AntibodystaleMerck Sharp & Dohme LLCPhase 2

Robatumumab (Robatumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2

임상시험 2상태 DISCONTINUED

51 / 167 페이지

← 이전 다음 →

전체 9,268개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 0 / 572

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

AZD9592 (AZD9592)

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

Anti-CD19 UCAR-NK cells (Anti-CD19 UCAR-NK cells)

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

SEA-TGT (SEA-TGT)

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

CD30.CAR-EBVST cells (CD30.CAR-EBVST cells)

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

OriCAR-017 (OriCAR-017)

AD CP (AD CP)

IM19 CAR-T cells (IM19 CAR-T cells)

D2E7 (adalimumab, adalimumab (D2E7))

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

Descartes-08 (Descartes-08)

CART-19 cells (CART-19 cells)

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

RC98 (RC98)

FDA022-BB05 (FDA022-BB05)

infliximab, azathioprine (infliximab, azathioprine)

AAV BBP-631 (AAV BBP-631)

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Bevacizumab Injection [Avastin] (Bevacizumab Injection [Avastin])

brentuximab vedotin (Adcetris, Induction without Brentuximab Vedotin)

Cetuximab, Capecitabine (Cetuximab, Capecitabine)

Robatumumab (Robatumumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

AZD9592 (AZD9592)

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

Anti-CD19 UCAR-NK cells (Anti-CD19 UCAR-NK cells)

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

SEA-TGT (SEA-TGT)

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

CD30.CAR-EBVST cells (CD30.CAR-EBVST cells)

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

OriCAR-017 (OriCAR-017)

AD CP (AD CP)

IM19 CAR-T cells (IM19 CAR-T cells)

D2E7 (adalimumab, adalimumab (D2E7))

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

Descartes-08 (Descartes-08)

CART-19 cells (CART-19 cells)

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

RC98 (RC98)

FDA022-BB05 (FDA022-BB05)

infliximab, azathioprine (infliximab, azathioprine)

AAV BBP-631 (AAV BBP-631)

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Bevacizumab Injection [Avastin] (Bevacizumab Injection [Avastin])

brentuximab vedotin (Adcetris, Induction without Brentuximab Vedotin)

Cetuximab, Capecitabine (Cetuximab, Capecitabine)

Robatumumab (Robatumumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

AZD9592 (AZD9592)

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

Anti-CD19 UCAR-NK cells (Anti-CD19 UCAR-NK cells)

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

SEA-TGT (SEA-TGT)

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

CD30.CAR-EBVST cells (CD30.CAR-EBVST cells)

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

OriCAR-017 (OriCAR-017)

AD CP (AD CP)

IM19 CAR-T cells (IM19 CAR-T cells)

D2E7 (adalimumab, adalimumab (D2E7))

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

Descartes-08 (Descartes-08)

CART-19 cells (CART-19 cells)

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)